Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Rank in Stocks #39467
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Share Price
$0.11725176
Last synced: 2025-07-14
Market Cap
$481.50K
Change (1 day)
-0.20%
Change (1 year)
0.00%
Country
FR
Trade PHAXIAM Therapeutics S.A. (PHXM)

Category

Stock split history for PHAXIAM Therapeutics S.A. (PHXM)
PHAXIAM Therapeutics S.A. stock (symbol: PHXM) underwent a total of 2 stock splits.
The most recent stock split occurred on Jun 13, 2024.
One PHXM share bought prior to Sep 18, 2023 would equal to 0.10819672131148 PHXM shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2024-06-13 66:61 x1.0819672131148 x0.10819672131148
2023-09-18 1:10 x0.1 x0.1
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE